Hantech Bio-Technology Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 3/6
Hantech Bio-Technology has been growing earnings at an average annual rate of 83.8%, while the Personal Products industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 67.5% per year. Hantech Bio-Technology's return on equity is 38.5%, and it has net margins of 23.1%.
Anahtar bilgiler
83.8%
Kazanç büyüme oranı
79.5%
EPS büyüme oranı
| Personal Products Sektör Büyümesi | 13.9% |
| Gelir büyüme oranı | 67.5% |
| Özkaynak getirisi | 38.5% |
| Net Marj | 23.1% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
Gelir ve Gider Dağılımı
Hantech Bio-Technology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 775 | 179 | 99 | 8 |
| 31 Mar 24 | 725 | 174 | 93 | 8 |
| 31 Dec 23 | 625 | 148 | 88 | 7 |
| 31 Dec 22 | 303 | 47 | 62 | 8 |
Kaliteli Kazançlar: 1294 has a high level of non-cash earnings.
Büyüyen Kar Marjı: 1294's current net profit margins (23.1%) are higher than last year (21.1%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: Unable to establish if 1294's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Büyüme Hızlandırma: Unable to compare 1294's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Kazançlar vs. Sektör: 1294 earnings growth over the past year (83.8%) exceeded the Personal Products industry -1%.
Özkaynak Getirisi
Yüksek ROE: 1294's Return on Equity (38.5%) is considered high.